CUSIP 880881107COM430Q4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
245 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 8.19M | $331.05M | +2.64M | Added |
| 2 | Morgan Stanley | 7.95M | $321.00M | +356.5K | Added |
| 3 | Adage Capital Partners Gp, L.L.C. | 5.55M | $224.22M | +1.61M | Added |
| 4 | Vanguard Group Inc | 5.52M | $223.17M |
| Added |
| 5 | Vivo Capital, LLC | 5.35M | $216.02M | −1.55M | Reduced |
| 6 | Vestal Point Capital, LP | 4.50M | $181.80M | +4.50M | New |
| 7 | Janus Henderson Group PLC | 3.38M | $136.50M | +3.38M | New |
| 8 | Citadel Advisors LLC | 3.17M | $127.93M | +1.58M | Added |
| 9 | Capitolis Liquid Global Markets LLC | 3.05M | $123.03M | +3.05M | New |
| 10 | Holocene Advisors, LP | 2.78M | $112.13M | +2.78M | New |
See every fund holding Terns Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders